Acyclovir
Acyclovir is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Acyclovir; Generic name: ACYCLOVIR; Drug class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC].
| Brand name | Acyclovir |
|---|---|
| Generic name | ACYCLOVIR |
| Drug class | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
| Manufacturer | Camber Pharmaceuticals, Inc. |
| Used for | INDICATIONS AND USAGE Herpes Zoster Infections: Acyclovir tablets, USP are indicated for the acute treatment of herpes zoster (shingles). Genital Herpes: Acyclovir tablets, USP are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox: Acyclovir tablets, USP are indicated for the treatment of chickenpox (varicella). |
| Dosage | DOSAGE AND ADMINISTRATION Acute Treatment of Herpes Zoster: 800 mg every 4 hours orally, 5 times daily for 7 to 10 days. Genital Herpes: Treatment of Initial Genital Herpes: 200 mg every 4 hours, 5 times daily for 10 days. Chronic Suppressive Therapy for Recurrent Disease: 400 mg 2 times daily for up to 12 months, followed by re-evaluation. Alternative regimens have included doses ranging from 200 mg 3 times daily to 200 mg 5 times daily. The frequency and severity of episodes of untreated genit |
| Warnings | WARNINGS Acyclovir tablets are intended for oral ingestion only. Renal failure, in some cases resulting in death, has been observed with acyclovir therapy (see ADVERSE REACTIONS: Observed During Clinical Practice and OVERDOSAGE ). Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), which has resulted in death, has occurred in immunocompromised patients receiving acyclovir therapy. Severe cutaneous adverse reactions (SCARs), including acute generalized exanthematous pustulosi |
| Active ingredient(s) | ACYCLOVIR |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0910335b-6796-459f-b97e-d7ef5439a060 |